Cargando…
Correction: Antibody targeting TSPAN12/β-catenin signaling in vasoproliferative retinopathy
Autores principales: | Bucher, Felicitas, Friedlander, Martin, Yea, Kyungmoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145699/ https://www.ncbi.nlm.nih.gov/pubmed/30237865 http://dx.doi.org/10.18632/oncotarget.26102 |
Ejemplares similares
-
Antibody targeting TSPAN12/β-catenin signaling in vasoproliferative retinopathy
por: Bucher, Felicitas, et al.
Publicado: (2017) -
CNTF Attenuates Vasoproliferative Changes Through Upregulation of SOCS3 in a Mouse-Model of Oxygen-Induced Retinopathy
por: Bucher, Felicitas, et al.
Publicado: (2016) -
Correction: TSPAN6 is a suppressor of Ras-driven cancer
por: Humbert, Patrick O., et al.
Publicado: (2022) -
Combined rhegmatogenous and traction detachment associated with vasoproliferative tumor secondary to sickle cell retinopathy
por: Wang, Qiancheng, et al.
Publicado: (2016) -
Retinal Vasoproliferative Tumor in Ocular Albinism
por: Alsakran, Wael A., et al.
Publicado: (2020)